1,044 results on '"Syngal, Sapna"'
Search Results
202. Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The genetic education, risk assessment and testing (GENERATE) study.
203. Sa1350 – Updated International Cancer of the Pancreas Screening (CAPS) Consortium Guidelines on the Management of Patients with Increased Risk for Familial Pancreatic Cancer
204. Benefits of Colonoscopic Surveillance and Prophylactic Colectomy in Patients with Hereditary Nonpolyposis Colorectal Cancer Mutations
205. Review: Nonsteroidal Antiinflammatory Drugs and the Gastrointestinal Tract: The Double-Edged Sowrd
206. Comparison of Colorectal and Endometrial Microsatellite Instability Tumor Analysis and Premm5 Risk Assessment for Predicting Pathogenic Germline Variants on Multigene Panel Testing.
207. Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer.
208. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
209. Intercepting Pancreatic Cancer
210. Precision Prevention and Early Detection of Cancer: Fundamental Principles
211. Germline Genetic Testing for Pancreatic Ductal Adenocarcinoma at Time of Diagnosis
212. Poor performance of clinical prediction models: the harm of commonly applied methods
213. Clinical factors associated with urinary tract cancers (UTCs) among Lynch syndrome (LS) patients (Pts).
214. Implementing universal genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts).
215. Patient and provider perspectives on adherence to and care coordination of lynch syndrome surveillance recommendations: findings from qualitative interviews
216. Relationship between individual and family characteristics and psychosocial factors in persons with familial pancreatic cancer
217. Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer
218. Inherited DNA-Repair Defects in Colorectal Cancer
219. Community Practice Implementation of a Self-administered Version of PREMM1,2,6 to Assess Risk for Lynch Syndrome
220. Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer
221. Detection and Treatment of Pancreatic Cancer and High-Grade Precursor Lesions in High-Risk Individuals Undergoing Surveillance: Results From the International CAPS Consortium Registry
222. Reply to M.S. Daniels et al
223. Abstract 4272: Mutations in RABL3 alter RAS prenylation and are associated with hereditary pancreatic cancer
224. Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome
225. Biallelic Mismatch Repair Deficiency: Management and Prevention of a Devastating Manifestation of the Lynch Syndrome
226. A Blood-Based Marker Panel for Detection of Colorectal Neoplasia
227. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer
228. Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome
229. Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives
230. Comparison of Colonoscopy Quality Measures Across Various Practice Settings and the Impact of Performance Scorecards
231. KRAS and GNAS Mutations in Pancreatic Juice Collected From the Duodenum of Patients at High Risk for Neoplasia Undergoing Endoscopic Ultrasound
232. Health behaviours and beliefs in individuals with familial pancreatic cancer.
233. A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene.
234. Implementation of a Systematic Tumor Screening Program for Lynch Syndrome in an Integrated Health Care Setting.
235. Recent advances in Lynch syndrome.
236. Gastrointestinal Cancer Precursor Conditions and their Detection
237. Phenotypic Characteristics Associated With the APC Gene 11307K Mutation in Ashkenazi Jewish Patients With Colorectal Polyps
238. Therapy-associated polyposis – a novel form of acquired gastrointestinal polyposis
239. Universal Screen for Lynch Syndrome in an Integrated Health Care System: Assessment of Patient Perspectives and Sharing Results With At-Risk Relatives
240. A proposed staging system and stage-specific interventions for familial adenomatous polyposis
241. Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study
242. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review
243. Association of a let-7 miRNA binding region ofTGFBR1with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC)
244. Identification of Lynch syndrome (LS) in patients (pts) without prior LS-associated cancer.
245. Prevalence of germline cancer susceptibility gene mutations in a consecutive series of 799 colorectal cancer (CRC) patients (pts).
246. Oncogastroenterology
247. 1145 Detection and Treatment of Pancreatic Cancer and High-Grade Precursor Lesions in High-Risk Individuals Undergoing Surveillance: Results From the International CAPS Consortium Registry
248. ReCAP: Oncologists’ Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer
249. Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators
250. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.